|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.05 USD | +24.48% |
|
-22.26% | -33.92% |
| 12-05 | Top Premarket Decliners | MT |
| 11-11 | Quoin Pharmaceuticals Announces Achievement of Topical Rapamycin Target Loadings for Two Proprietary Delivery Technologies | CI |
EPS & Dividend: Quoin Pharmaceuticals, Ltd.
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - |
| EPS 2 | -28,455 | -1,638 | -337.4 | -66.85 | -20.16 | -6.91 | -0.52 |
| Distribution rate | - | - | - | - | - | - | - |
| Reference price 2 | 9,555.01 | 596.40 | 171.68 | 22.77 | 15.05 | 15.05 | 15.05 |
| Nbr of stocks (in thousands) | 1.59 | 11.5 | 28.2 | 234 | 839 | - | - |
| Announcement Date | 14/04/22 | 09/03/23 | 13/03/24 | 13/03/25 | - | - | - |
1USD in Million2USD
Estimates
Upcoming events: Quoin Pharmaceuticals, Ltd.
| 11/03/2026 | Q4 2025 Earnings Release (Projected) |
| 12/05/2026 | Q1 2026 Earnings Release (Projected) |
| 05/08/2026 | Q2 2026 Earnings Release (Projected) |
| 04/11/2026 | Q3 2026 Earnings Release (Projected) |
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | ||
|---|---|---|---|---|---|---|
 | - | - | -0.75x | - | - | |
| 0.91% | 1.03% | 38.08x | 3.93x | 5.55x | |
| -.--% | -.--% | 31.47x | 6x | 3.18x | |
| -.--% | -.--% | 104.89x | 9.03x | 6.39x | |
| 0.4% | 0.42% | 52.55x | 2.33x | 10.13x | |
| -.--% | -.--% | 37.1x | 37.04x | 6x | |
| -.--% | -.--% | -14.35x | 9.75x | 5595.1x | |
| -.--% | -.--% | 28.19x | 1.49x | 2.1x | |
| -.--% | -.--% | -51.84x | 33.78x | 11.17x | |
| -.--% | -.--% | -36.2x | 47.95x | 13.71x | |
| Average | 0.14% | 0.16% | 18.92x | 16.81x | 628.15x | |
| Weighted average by Cap. | 0.24% | 0.27% | 35.32x | 11.95x | 397.03x |
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition